Search Results 1161-1170 of 16425 for anti-TNF drugs
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
By condition, treatment or drug name ... drugs throughout this study. Embedded within the ... endocrine or anti-endocrine therapies.] Exclusion ...
Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. Participation ...
Physical Medicine and Rehabilitation at Mayo Clinic offers treatment and specialty care to people with a wide range of musculoskeletal, brain, spine and ...
An assessment of Mayo Clinic's new approach to radiation therapy for diffuse midline glioma. Laboratory studies of potential new therapies and drug-delivery ...
Now researchers at Mayo have decoded one of those tricks using cell lines and patient-derived cancer cells, and proposed a way to resensitize breast cancer ...
... therapy (abiraterone acetate, enzalutamide, apalutamide, or investigational AR-targeted agent); treatment with the older anti-androgen therapies such as ...
Received daily nonsteroidal anti-inflammatory drugs (NSAIDs) ≤14 days prior to registration; Received immunomodulating or immunosuppressive therapy as follows:.
The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for treatment with brexucabtagene ...
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.